Back to search
FDAFDA · Food and drugs·Recall number D-0754-2021

Carvedilol 25 mg, 180-count bottle, Rx only, Manufactured by Zydus Pharm, Pennington, NJ 08534, NDC 68382-0095-05, Repackaged by RemedyRepack Inc., Indiana, PA 15701, NDC 70518-1826-01

Published September 1, 2021 · Recall initiated: August 17, 2021

Summary

FDA records drug Class II recall D-0754-2021, published September 1, 2021 and initiated August 17, 2021. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 4; Lot: Lot # B1273286-071521, Exp 07/31/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A 500 count bottle of Carvedilol 25 mg tablets contained two Paroxetine Tablets, 40 mg. Product was repackaged into 180 count bottles.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
Product was distributed to two medical facilities in VA and FL.
Lot
Lot # B1273286-071521, Exp 07/31/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carvedilol 25 mg, 180-count bottle, Rx only, Manufactured by Zydus Pharm, Pennington, NJ 08534, NDC 68382-0095-05, Repackaged by RemedyRepack Inc., Indiana, PA 15701, NDC 70518-1826-01 recalled?

Yes. FDA published recall D-0754-2021 on September 1, 2021. Reported hazard: A 500 count bottle of Carvedilol 25 mg tablets contained two Paroxetine Tablets, 40 mg. Product was repackaged into 180 count bottles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter